- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
© 2020 MJH Life Sciences and Endocrinology Network. All rights reserved.
All News
New Guidance for Treating Diabetic COVID-19 Patients in the ICU
June 10, 2020
According to the report, more than 20 percent of COVID patients in the ICU are patients with diabetes, presenting challenges for the clinicians managing their care. Diabetic patients with COVID-19 in the ICU need both complex medical management of their COVID disease, along with blood sugar control to minimize complications and mortality risk- and that can require multiple patient interactions that put the provider at risk.
ACE’s and ARBs Not Linked to COVID-19 Mortality But Hypertension Doubles Risk
June 09, 2020
Hypertensive patients have a two-fold increased risk of dying from the coronavirus COVID-19 compared to patients without high blood pressure, according to new research published in the European Heart Journal. In addition, if the hypertension is untreated, the risk is greater.
Mortality Estimates in Elderly Atherosclerosis Patients Improved By Knowledge of Exercise Habits
June 09, 2020
When asked to elderly patients undergoing coronary artery calcium (CAC) scans, the results of a single question offer providers a better understanding of the individual’s risk of death: "On a scale of 1 - 10, how much do you exercise (0-none, 10-always)?"
Diabetes and Heart Disease? Adherence to Antihypertensive Drugs Increase Life Expectancy in Frail Elderly Populations
June 08, 2020
When antihypertensive medications are taken with regularity, life expectancy is increased says a new study published in the American Heart Association Journal Hypertension.
Chemical Exposure May Cause Early Menopause
June 03, 2020
Women exposed to Per- and polyfluoroalkyl substance (PFAS), a chemical commonly used in nonstick and waterproof products and firefighting foams, experience menopause earlier according to a study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Ticagrelor Now For Use in Diabetic Patients Without History of MI or Stroke Says FDA
June 02, 2020
The oral antiplatelet drug Ticagrelor (Brilinta, Astra Zeneca), was approved this week by the US Food and Drug Administration (FDA) for use in patients with coronary artery disease (CAD) who are at high risk for a first heart attack or stroke. The change adds new treatment options to diabetic pateints at high risk for cardiac events.
Oral Diabetes Drugs May Improve Survival In Diabetics With Colorectal Cancer
June 02, 2020
A common problem among diabetic patients is adherence to medications. A new study has found that colorectal cancer patients who are compliant in taking oral diabetes drugs fare better than those who do not.
Image IQ: 50 year old man with nausea, vomiting, mental status change and rash
June 01, 2020
How good are your diagnostic skills? Test them here with this month's Visual Dx quiz!
57th ERA-EDTA Congress: Virtual Press Conference on Coronavirus and the Kidneys June 5th
May 29, 2020
SARS-CoV-2 affects renal function, and some patients have been known to develop acute kidney injury (AKI). Kidney patients are also at greater risk from coronavirus. On June 5 at 3.30 pm CEST, experts will convene in a special online Zoom session of the ERA-EDTA (European Renal Association and European Dialysis and Transplant Association). to discuss the relationship between coronavirus and kidney function.